Vertex Financial News

16.11 / 13:27
Extreme Healthcare Vertex reports patient medicines malaria Britain approves world's first gene therapy Casgevy for sickle cell disease and thalassemia
thalassemia. The Medicines and Healthcare Regulatory Agency on Thursday said that it approved Casgevy for patients with sickle cell disease and thalassemia who are 12 years old and over. Casgevy is made by Vertex Pharmaceuticals (Europe) Ltd.
27.10 / 19:12
Vertex hospital reports testing patient medicines malaria advisers week A new cure for sickle cell disease may be coming. Health advisers will review it next week
There soon may be a new cure for sickle cell disease that attacks the disorder at its genetic source
23.10 / 13:11
Digital Booking CEO WhatsApp Vertex Fintech lender RING's FY23 revenue jumps 100%, profit at ₹95.5 crore
₹1,037 crore for FY23, a 100% growth from ₹517 crore clocked in the previous year. Profit stood at ₹95.5 crore in FY23 compared with ₹65 crore a year ago, the company said in a statement. The Mumbai-based fintech startup, founded in 2015 by Ranvir Singh and Krishnan Vishwanathan, claims to have a customer base of over 10 million with about 4 million customers onboarded over the last 12 months.
23.10 / 11:57
Digital Booking CEO WhatsApp Vertex Fintech lender Kissht's FY23 revenue jumps 100%, profit at ₹95.5 crore
₹1,037 crore for FY23, a 100% growth from ₹517 crore clocked in the previous year. Profit stood at ₹95.5 crore in FY23 compared with ₹65 crore a year ago, the company said in a statement. The Mumbai-based fintech startup, founded in 2015 by Ranvir Singh and Krishnan Vishwanathan, claims to have a customer base of over 10 million with about 4 million customers onboarded over the last 12 months.
02.10 / 16:47
UPS Landmark Platform Vertex Shell Shell company Vertex Tech to buy streaming platform 17Live for $676 million in landmark deal for Singapore
Singapore's Vertex Technology Acquisition Corp (VTAC) will buy live streaming platform 17LIVE Inc for up to S$925.1 million ($676 million), the special purpose acquisition company (SPAC) backed by state investor Temasek said on Monday. The deal is the first purchase of a private company by a SPAC listed in the city-state since 2021 when the Singapore Exchange allowed SPACs, or shell firms, to float shares in a bid to position itself as a hub for this type of vehicle in Asia.
20.09 / 08:41
Digital Booking Google Platform Align Vertex voice Kuku FM raises $25 million in funding from Fundamentum, others
Kuku FM on Wednesday said it has raised $25 million in a Series C funding round co-led by the Nandan Nilekani-founded Fundamentum Partnership and International Finance Corporation. Temasek-backed Vertex Ventures, which closed its fifth fund at $541 million last week, also participated in the funding, as per a statement.
18.09 / 13:59
Target Action Parke Vertex Androgenetic Alopecia Research: PTD-DBM Peptide
PTD-DBM exhibited promising potential in facilitating hair regrowth. Research suggests the peptide may possibly inhibit loss by regulating this biological pathway. Androgenetic alopecia is considered to have notable physiological and psychological impacts on models affected by it.
15.09 / 02:49
Reuters Digital Google Software Gemini Vertex Google nears release of AI software Gemini: report
Google has given a small group of companies access to an early version of Gemini, its conversational artificial intelligence software, The Information reported on Thursday, citing people familiar with the matter. Gemini is intended to compete with OpenAI's GPT-4 model, according to the report.
04.09 / 04:25
Extreme Enterprise SENSEX Vertex band Power services Financial BSE revises circuit limit for 10 stocks including Jio Financial Services, RailTel, RattanIndia Power
RailTel Corporation of India, India Pesticides and RattanIndia Power. BSE uses a circuit filter mechanism to keep in check excessive volatility in a scrip. It is the maximum fluctuation that is allowed in a stock in a day.
28.07 / 15:11
Lowe's Merck Moderna Pfizer CVS Vertex Gilead week Pro Research of the Week: Is Pfizer the Best Bet Among Big Pharma Stocks?
Earnings season is in full swing, and next week, we've got our sights set on the healthcare sector, specifically pharmaceutical and biotechnology companies, as they get ready to reveal their quarterly results.

frequently asked questions about Vertex

What is Vertex and why is it gaining attention?

Vertex is a trending topic that draws public attention. On our site, we regularly publish articles related to this subject.

Where can I find the latest updates on Vertex?

All new posts about Vertex can be found in the dedicated section. We publish information as it becomes available.

How can I verify the accuracy of information on Vertex?

We use verified data to ensure that the information about Vertex is well-supported and helpful for our readers.